Effects of preanalytical variables on the quality of biospecimens used to study genetic changes in cancer: development of the biospecimen research database
by Rand Infrastructure, Safety, and Environment (Organization), Transportation, Space, and Technology Program (Rand Corporation), Eiseman, Elisa, National Cancer Institute (U.S.), Rand Corporation
fromDocumented briefing (Rand Corporation)
The National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research (OBBR) asked the RAND Corporation to identify and analyze existing data on the effects of preanalytical variables on biospecimens used to study genetic and proteomic changes in cancer. The pro…